drugset / Trial / NCT00236639
A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to compare the efficacy and safety of topiramate (96, 192, and 256mg daily) with placebo in long-term treatment of obesity.
Timeline
- Start
- 2000-07
- Primary completion
- —
- Completion
- 2002-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Topiramate | Small molecule | 96 mg | Oral |
| Subject | Topiramate | Small molecule | 192 mg | Oral |
| Subject | Topiramate | Small molecule | 256 mg | Oral |